Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Detecting Early Onset Pre-eclampsia and Use of Placental Growth Factor (PlGF) for Marker of Trisomy 21 (PlGF)

This study has been terminated.
(The technique has been approved and validated)
Information provided by (Responsible Party):
OVO R & D Identifier:
First received: January 31, 2011
Last updated: July 24, 2015
Last verified: July 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2015
  Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)